ACDIMA

As part of Arab joint action to encourage the pharmaceutical industry, the Arab Economic Unity Council decided to establish an Arab institution capable of fulfilling this mission: the Arab Company for Pharmaceutical Industries and Medical Supplies, "ACDIMA" on March 6, 1976, with an initial capital of 60 million Kuwaiti Dinars. This capital was raised to 90 million Kuwaiti Dinars with the approval of the extraordinary general assembly held in Amman, Jordan, on October 10, 2013, in accordance with the Riyadh Declaration of 2013, which approved an increase of at least 50% in the capital of joint Arab companies. The paid-up capital currently stands at 83,930,000 Kuwaiti Dinars.

Acdima at glance

1976

Company Establishment

90M KWD

Capital Investment

150 employees

Number of employees

13 Companies

Affiliated Companies

10 Countries

Countries

48 Years

Experience

17 stakeholders

Number of stakeholders

“Our primary focus is Suport, manufacturing & marketing high quality products to meet the healthcare needs and elevate the quality of life in the arab word ”

ACDIMA Bio Center

ACDIMA Center for bioequivalence and pharmaceutical studies is a contract research organization based in Jordan. Established in 2000 to be one of the first BioCenters in Jordan with two decades of experience and more than 750 bioequivalence studies to produce top-notch pharmaceutical solutions around the world. With the increased demand for exceptional services, ACDIMA is striving to offer extraordinary outcomes to maintain and exceed its spot as one of the best bioequivalence centers, not only in Jordan, but in the whole region.

follow the link